Home › NDC Lookup › RxCUI directory › RxCUI 994430

Aspirin 1000 MG / caffeine 65 MG Oral Powder — RxCUI 994430

Name: Aspirin 1000 MG / caffeine 65 MG Oral Powder (RxCUI 994430)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 994430 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI994430

Official nameAspirin 1000 MG / caffeine 65 MG Oral Powder

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asASA 1000 MG / Caffeine 65 MG Oral Powder; ASA 1,000 MG / caffeine 65 MG Oral Powder

FDA products mapped1

Package NDCs mapped3

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aspirin Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Great question. A rectal suppository gets the medication into your system through the lining of the rectum rather than your stomach. This can be helpful if you're having trouble sw...
Why would someone use a rectal suppository instead of just taking aspirin by mouth?
First, check that the foil or plastic packet is fully sealed and undamaged before you open it — don't use it if it looks like it's already been opened. Once you open it, insert the...
This is really important: aspirin — including the suppository form — should NOT be given to children or teenagers who have or are recovering from chicken pox or the flu. There is a...

📖 Read our full Aspirin Rectal guide →

🕸️ Concept Web — How Aspirin 1000 MG / caffeine 65 MG Oral Powder Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Aspirin 1000 MG / caffeine 65 MG Oral Powder RxCUI 994430 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 3

The active substance itself — no strength, form, or brand attached yet.
- Aspirin 1191 IN
- Caffeine 1886 IN
- Aspirin / caffeine 214250 MIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- BC Arthritis 1247393 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Aspirin / caffeine Oral Powder 900527 SCDF
- Aspirin / caffeine Oral Powder Product 1294849 SCDG
- Aspirin / caffeine Oral Product 1153525 SCDG
- Aspirin / caffeine Oral Powder [BC Arthritis] 1247395 SBDF
- BC Arthritis Oral Powder Product 1295836 SBDG
- BC Arthritis Oral Product 1247396 SBDG
- Oral Powder 346289 DF
- Oral Powder Product 1294711 DFG
- +1 more in this family
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Aspirin 1000 MG 994429 SCDC
- Caffeine 65 MG 317311 SCDC
- Aspirin 1000 MG / caffeine 65 MG Oral Powder [BC Arthritis] 1247397 SBD
- Aspirin 1000 MG / caffeine 65 MG [BC Arthritis] 1247394 SBDC

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Aspirin 1000 MG SCDC · 994429
Caffeine 65 MG SCDC · 317311
Aspirin / caffeine Oral Powder SCDF · 900527
Aspirin / caffeine Oral Powder Product SCDG · 1294849
Aspirin / caffeine Oral Product SCDG · 1153525

Brand-Name Concepts

Aspirin 1000 MG / caffeine 65 MG Oral Powder [BC Arthritis] SBD · 1247397
Aspirin 1000 MG / caffeine 65 MG [BC Arthritis] SBDC · 1247394
Aspirin / caffeine Oral Powder [BC Arthritis] SBDF · 1247395
BC Arthritis Oral Powder Product SBDG · 1295836
BC Arthritis Oral Product SBDG · 1247396
BC Arthritis BN · 1247393

📦 FDA Products & Package NDCs

1 product · 3 package NDCs

3 package NDCs map to RxCUI 994430 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
63029-0990-02	24 POWDER in 1 BOX (63029-990-02)	BC Arthritis	Medtech Products Inc.	2012-06-01
63029-0990-06	6 POWDER in 1 PACKAGE (63029-990-06)	BC Arthritis	Medtech Products Inc.	2012-06-01
63029-0990-50	50 POWDER in 1 CARTON (63029-990-50)	BC Arthritis	Medtech Products Inc.	2012-06-01

Observed labelers: Medtech Products Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.